Novo Integrated Sciences Inc (NASDAQ:NVOS) shares, rose in value, with the stock price up by 6.56% to the previous day’s close as strong demand from buyers drove the stock to $0.50.
Actively observing the price movement in the last trading, the stock closed the session at $0.47. The value of beta (5-year monthly) was -0.61. Referring to stock’s 52-week performance, its high was $5.38, and the low was $0.43. On the whole, NVOS has fluctuated by -20.67% over the past month.
With the market capitalization of Novo Integrated Sciences Inc currently standing at about $8.39 million, investors are eagerly awaiting this quarter’s results, scheduled for May 24, 2024 – May 28, 2024.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that NVOS’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of NVOS currently trading nearly -7.40% and -22.22% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 42.12, while the 7-day volatility ratio is showing 12.11% which for the 30-day chart, stands at 12.75%. Furthermore, Novo Integrated Sciences Inc (NVOS)’s beta value is -0.61, and its average true range (ATR) is 0.07.
A comparison of Novo Integrated Sciences Inc (NVOS) with its peers suggests the former has fared considerably weaker in the market. NVOS showed an intraday change of 6.56% in last session, and over the past year, it shrunk by -58.42%%.
Data on historical trading for Novo Integrated Sciences Inc (NASDAQ:NVOS) indicates that the trading volumes over the past 10 days have averaged 0.43 million and over the past 3 months, they’ve averaged 569.05K. According to company’s latest data on outstanding shares, there are 15.76 million shares outstanding.
Nearly 7.32% of Novo Integrated Sciences Inc’s shares belong to company insiders and institutional investors own 5.90% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.56 million shares as on Mar 15, 2024, resulting in a short ratio of 0.89. According to the data, the short interest in Novo Integrated Sciences Inc (NVOS) stood at 3.18% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 0.53 million. The stock has fallen by -39.22% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the NVOS stock heading into the next quarter.
